Metabolic Tumor Burden Assessed by Dual Time Point [18F]FDG PET/CT in Locally Advanced Breast Cancer: Relation with Tumor Biology
Autor: | Ángel Soriano-Castrejón, David Molina, Víctor M. Pérez-García, Julián Pérez-Beteta, Ana María García-Vicente, German Andrés Jiménez-Londoño, Alicia Martínez-González |
---|---|
Rok vydání: | 2016 |
Předmět: |
Oncology
Cancer Research medicine.medical_specialty Multivariate analysis medicine.diagnostic_test business.industry medicine.drug_class Standardized uptake value medicine.disease 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Breast cancer Positron emission tomography Hormone receptor Estrogen 030220 oncology & carcinogenesis Internal medicine Progesterone receptor Medicine Radiology Nuclear Medicine and imaging business Nuclear medicine Grading (tumors) |
Zdroj: | Molecular Imaging and Biology. 19:636-644 |
ISSN: | 1860-2002 1536-1632 |
DOI: | 10.1007/s11307-016-1034-x |
Popis: | The aim of the study was to investigate the influence of dual time point 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) positron emission tomography/x-ray computed tomography (PET/CT) on the standard uptake value (SUV) and volume-based metabolic variables of breast lesions and their relation with biological characteristics and molecular phenotypes. Retrospective analysis including 67 patients with locally advanced breast cancer (LABC). All patients underwent a dual time point [18F]FDG PET/CT, 1 h (PET-1) and 3 h (PET-2) after [18F]FDG administration. Tumors were segmented following a three-dimensional methodology. Semiquantitative metabolic variables (SUVmax, SUVmean, and SUVpeak) and volume-based variables (metabolic tumor volume, MTV, and total lesion glycolysis, TLG) were obtained. Biologic prognostic parameters, such as the hormone receptors status, p53, HER2 expression, proliferation rate (Ki-67), and grading were obtained. Molecular phenotypes and risk-classification [low: luminal A, intermediate: luminal B HER2 (−) or luminal B HER2 (+), and high: HER2 pure or triple negative] were established. Relations between clinical and biological variables with the metabolic parameters were studied. The relevance of each metabolic variable in the prediction of phenotype risk was assessed using a multivariate analysis. SUV-based variables and TLG obtained in the PET-1 and PET-2 showed high and significant correlations between them. MTV and SUV variables (SUVmax, SUVmean, and SUVpeak) where only marginally correlated. Significant differences were found between mean SUV variables and TLG obtained in PET-1 and PET-2. High and significant associations were found between metabolic variables obtained in PET-1 and their homonymous in PET-2. Based on that, only relations of PET-1 variables with biological tumor characteristics were explored. SUV variables showed associations with hormone receptors status (p |
Databáze: | OpenAIRE |
Externí odkaz: |